Highlights
NASDAQ: RIGL       Rigel Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
3.75   +0.05 (1.35%)  3.655 - 3.83  2,679,300

Overview

 
Avg Volume (4 weeks):2,434,983
4 Weeks Range:3.33 - 4.04
4 Weeks Price Volatility (%):
59.15%
52 Weeks Range:1.23 - 5.24
52 Weeks Price Volatility (%):
62.84%
Average Price Target: 10.00
Price Target Upside/Downside: +6.25

Headlines



No recent Headlines for this stock.


Business Background

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken over all responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes Fostamatinib - ITP, Fostamatinib - AIHA, Fostamatinib - IgAN, BGB324 - Oral AXL Inhibitor, ATI-50001 & 50002 - JAK Inhibitors, DS-3032-MDM2 Inhibitor, THF-beta Inhibitors and AZD0449- Inhaled JAK Inhibitor.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6239  2800  512  101 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00 

TOP ARTICLES

1. Wall Street Breakfast: Loon Goes Pop Wall Street Breakfast
2. Stocks Mixed on Labor Market Concerns State of The Markets
3. Wall Street Breakfast: Response To The Pandemic Wall Street Breakfast
4. Markets Cheered on Biden’s Policies State of The Markets
5. Daily Futures Trading Strategy 22 January 2021 Where Futures Lies